Table 3

Risk factors and incidence of VA in patients with TOF

No VA
(n=113)
VA
(n=35)
P valueORP value
Age at operation, years4.6±4.54.6±0.20.94
QRS duration, ms136±27147±340.06
NYHA class1 (1–3)1 (1–3)0.55
Exercise capacity, W151±38151±330.97
Operations, no0.8±0.91.0±0.80.26
RV FAC, %48.5±6.947.3±7.50.44
RV D1, cm4.3±0.54.6±0.60.012.4 (1.2 to 5.0)
2.8 (1.1 to 6.9)
0.01
0.025
RVOT, cm2.9±0.42.9±0.50.86
LV EF, %55±850±90.020.94 (0.90 to 0.99)0.02
LV MD, ms44±1449±160.09
LV GLS, %−17.7±3.3−16.5±3.90.09
RV MD, ms37±2242±170.22
RV GLS, %−18.1±4.0−16.1±4.80.041.1 (1.0 to 1.2)0.03
  • GLS, global longitudinal strain; LV, left ventricular; LVEF, left ventricular ejection fraction; MD, mechanical dispersion; RV, right ventricular; RVD1, right ventricular basal diameter; RVFAC, right ventricular fractional area change; RVOT, right ventricular outflow tract; TOF, tetralogy of Fallot; VA, ventricular arrhythmias.